Open AccessDifferential Outcomes Following 4 Weeks of Aclidinium/Formoterol in Patients with COPD: A Reanalysis of the ACTIVATE Study
Author(s) -
Marije Koopman,
Franssen FME,
Swetlana Gaffron,
Henrik Watz,
Thierry Troosters,
Judith GarciaAymerich,
Pierluigi Paggiaro,
Eduard Molins,
M Moya,
van Burk L,
Dieter Maier,
Garcia Gil E,
Wouters EFM,
Vanfleteren LEGW,
Spruit MA
Publication year - 2022
Publication title -
international journal of chronic obstructive pulmonary disease/international journal of copd
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.394
H-Index - 67
eISSN - 1178-2005
pISSN - 1176-9106
DOI - 10.2147/copd.s308600
Subject(s) - medicine , copd , formoterol , placebo , functional residual capacity , physical therapy , randomized controlled trial , lung volumes , minimal clinically important difference , spirometry , crossover study , pulmonary function testing , cardiology , asthma , lung , alternative medicine , pathology , budesonide